Market Tracker

12/18 6:05pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

During the Trading Day
30.79 +0.86 / +2.86%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
30.79 0.00 / 0.00%
 
Volume: 14.4K

Today’s Trading

Previous close29.93
Today’s open30.17
Day’s range29.89 - 30.95
Volume602,951
Average volume (3 months)623,746
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+55.67%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)-12.07%
P/E ratio20.9
Price/Sales3.29
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp+0.22+4.24%
IRWDIronwood Pharmaceuti...+0.39+2.66%
WXWuxi Pharmatech Caym...+1.36+4.11%
CLVSClovis Oncology Inc+1.90+3.41%
Data as of 4:02pm ET, 12/18/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts